We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$53.6B
AUM Growth
+$2.66B
(+5.2%)
Cap. Flow
+$86.8M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
37.17%
Holding
821
New
56
Increased
227
Reduced
258
Closed
253
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$86.2M |
| 2 |
Alcon
ALC
|
+$81.8M |
| 3 |
NVIDIA
NVDA
|
+$76M |
| 4 |
Corning
GLW
|
+$50.4M |
| 5 |
UnitedHealth
UNH
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$67.4M |
| 2 |
Factset
FDS
|
+$62M |
| 3 |
Euronet Worldwide
EEFT
|
+$42.3M |
| 4 |
Bank of America Series L
BAC.PRL
|
+$39.5M |
| 5 |
OPLN
Openlane
OPLN
|
+$31.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 17.74% |
| 3 | Financials | 11.65% |
| 4 | Healthcare | 11.2% |
| 5 | Communication Services | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Cemex
CX
$16.3B
| $11.2M | 0.02% |
2,646,082
| – | – |
|
|
CSFL
302
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $11.2M | 0.02% |
486,149
-58,593
| -11% | -$1.38M |
|
303
Helen of Troy
HELE
$693M
| $11.2M | 0.02% |
85,654
-2,051
| -2% | -$268K |
|
304
Vail Resorts
MTN
$5.3B
| $11.2M | 0.02% |
50,083
-16,868
| -25% | -$3.75M |
|
|
TPIC
305
DELISTED
TPI Composites
TPIC
| $11.1M | 0.02% |
450,930
-11,195
| -2% | -$286K |
|
306
Mid-America Apartment Communities
MAA
$15.7B
| $11.1M | 0.02% |
94,632
-4,737
| -5% | -$533K |
|
|
AVNS
307
DELISTED
Avanos Medical
AVNS
| $11M | 0.02% |
252,592
-17,301
| -6% | -$740K |
|
308
Acuity Brands
AYI
$10.8B
| $11M | 0.02% |
+79,565
| New | +$10.9M |
|
|
EVBG
309
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $10.9M | 0.02% |
122,308
-7,412
| -6% | -$585K |
|
310
Essential Properties Realty Trust
EPRT
$6.62B
| $10.7M | 0.02% |
533,869
+133,227
| +33% | +$2.72M |
|
311
Amphenol
APH
$209B
| $10.6M | 0.02% |
442,396
-22,624
| -5% | -$544K |
|
312
Tractor Supply
TSCO
$18B
| $10.5M | 0.02% |
480,655
-24,430
| -5% | -$505K |
|
|
PRA
313
DELISTED
ProAssurance
PRA
| $10.3M | 0.02% |
285,404
+56,237
| +25% | +$2.09M |
|
314
Wabtec
WAB
$49.3B
| $10.3M | 0.02% |
143,039
+20,099
| +16% | +$1.42M |
|
315
Old Dominion Freight Line
ODFL
$44.9B
| $10.2M | 0.02% |
205,971
-9,942
| -5% | -$484K |
|
|
CTB
316
DELISTED
Cooper Tire & Rubber Co.
CTB
| $10M | 0.02% |
317,184
-5,328
| -2% | -$162K |
|
317
Ashland
ASH
$3.5B
| $9.99M | 0.02% |
124,882
-2,982
| -2% | -$230K |
|
318
Lear
LEA
$8.18B
| $9.94M | 0.02% |
71,382
+11,341
| +19% | +$1.59M |
|
319
Neurocrine Biosciences
NBIX
$16.6B
| $9.94M | 0.02% |
117,672
-7,085
| -6% | -$582K |
|
320
Kirby Corp
KEX
$6.93B
| $9.91M | 0.02% |
125,454
+23,798
| +23% | +$1.91M |
|
321
Semtech
SMTC
$13B
| $9.74M | 0.02% |
202,771
-12,255
| -6% | -$595K |
|
322
NNN REIT
NNN
$8.99B
| $9.72M | 0.02% |
183,379
-13,978
| -7% | -$746K |
|
323
First Financial Bankshares
FFIN
$4.97B
| $9.72M | 0.02% |
315,680
-30,890
| -9% | -$929K |
|
324
Viavi Solutions
VIAV
$9.66B
| $9.72M | 0.02% |
731,373
-17,958
| -2% | -$232K |
|
325
Methode Electronics
MEI
$592M
| $9.67M | 0.02% |
338,392
-16,310
| -5% | -$457K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2019 Portfolio in Review
As of Q2 2019, Loomis, Sayles & Company held 821 positions worth $53.6B, up 5.2% from $50.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Loomis, Sayles & Company's Q2 2019 filing shows 56 new, 227 increased, 258 reduced and 253 closed positions. Its largest new stake was Alcon: 1,393,674 shares worth $86.5M. The largest sale was Novartis, an estimated $67.4M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q2 2019 buy was Alcon: 1,393,674 shares worth $86.5M.
- Loomis, Sayles & Company added most to Bristol-Myers Squibb in Q2 2019, an estimated $86.2M increase.
- Loomis, Sayles & Company's biggest Q2 2019 reduction was Novartis, cutting an estimated $67.4M.
- Loomis, Sayles & Company fully exited RingCentral in Q2 2019, selling an estimated $30.4M.
- Loomis, Sayles & Company's ten largest holdings make up 37% of its $53.6B portfolio in Q2 2019.
- Loomis, Sayles & Company opened 56 new positions and closed 253 in Q2 2019.
- Loomis, Sayles & Company's portfolio value rose 5.2% quarter-over-quarter to $53.6B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.